High antinuclear antibody titer is associated with increased mortality risk in patients with idiopathic pulmonary fibrosis

Shimon Izhakian*, May Igawa, Liora Chen Zion, Ori Mekiten, Lev Freidkin, Dror Rosengarten, Moshe Heching, Mordechai Reuven Kramer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'High antinuclear antibody titer is associated with increased mortality risk in patients with idiopathic pulmonary fibrosis'. Together they form a unique fingerprint.

Keyphrases

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology